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ABSTRACT We present a meanfield theoretical approach for studying protein–solvent interactions. Starting with the
partition function of the system, we develop a field theory by introducing densities for the different components of the system.
At this point, protein–solvent interactions are introduced following the inhomogeneous Flory–Huggins model for polymers.
Finally, we calculate the free energy in a meanfield approximation. We apply this method to study the stability of the
tetramerization domain of the tumor suppressor protein p53 when subjected to site-directed mutagenesis. The four chains
of this protein are held together by hydrophobic interactions, and some mutations can weaken this bond while preserving the
secondary structure of the single protein chains. We find good qualitative agreement between our numerical results and
experimental data, thus encouraging the use of this method as a guide in designing experiments.
INTRODUCTION
Understanding the relationship between the native confor-
mation of a protein and its amino acid sequence (“protein
folding problem”) has been one of the great issues of natural
sciences over the past decades (see e.g., Creighton, 1992).
Though the possible number of conformations of a polypep-
tide chain is immense, protein sequences fold into their
unique native structure within seconds (Levinthal, 1969).
Predicting this native structure for an arbitrary amino acid
sequence is still an unresolved problem.
It has been established that the amino acid side chains
each exist in a finite number of conformations (rotamers),
and early work has been devoted to the prediction of the
optimum side chain packing of a given amino acid sequence
and backbone conformation (Roitberg and Elbers, 1991;
Koehl and Delaru, 1994) using the rotamer libraries of
Ponders and Richards (1987) and Tuffery et al. (1991,
1993). Extensions of these approaches to homology models,
where a finite number of possible backbone conformations
are included into the packing algorithm are discussed by
Koehl and Delaru (1995, 1996) and Va`squez (1996). Re-
cently, the rotamer libraries have been refined by including
the backbone dependence of the different side chain con-
formations (Dunbrack and Karplus, 1993).
Early approaches for describing the protein-folding pro-
cess used lattice models with artificial residues (Lau and
Dill, 1989; Shakhanovich et al., 1991; Miller et al., 1992),
however, there are now more realistic models available
which try to predict the conformation of a given amino acid
sequence (see e.g., Kolinski and Skolnick, 1992, 1994;
Kolinski et al., 1993; Karplus and Weaver, 1994; Hinds and
Levitt, 1994; Srinivasan and Rose, 1995; Cheng et al., 1996;
Carlacci and Englander, 1996). It is beyond the scope of this
article to discuss (or even reference) all the work published
on protein folding, but extended reviews of this topic are
published by Creighton (1992), Karplus and S˘ali (1995),
and Levitt (1996).
A different problem is the prediction of the stability of a
protein subjected to site-directed mutagenesis. Here, the
starting point is a known protein structure and the task is to
find the relative change arising from mutant. If the back-
bone conformation of the mutant does not deviate from the
wild-type form, the problem reduces to finding the optimum
side chain packing using one of the above-mentioned search
algorithms. However, if the backbone structure changes
significantly with the mutation, one ends up again with the
protein-folding problem.
A systematic study of the stability of the  repressor
protein under a three-site mutation within its hydrophobic
core has been presented by Lee and Levitt (1991) and Lee
(1994), and compared to an exhaustive experimental study
by Lim and Sauer (1991). In the numerical approach, the
backbone was held fixed while the side chains were con-
sidered rather flexible with (almost) free rotating torsion
angles (the bond lengths and angles were kept fixed). By
comparing the energies of the mutants with the energy of
the wild-type structure and correlating these energy differ-
ences to the protein activity, Lee and Levitt (1991) and Lee
et al. (1994) found good agreement between their calcula-
tions and the experimental data. By confining their method
to the hydrophobic core region of a single polypeptide
chain, they ignored any solvent–protein interactions. This
approximation fails if mutations at the solvent–protein in-
terface or in the hydrophobic core of the quaternary struc-
ture of oligomeric proteins are considered. Here, interac-
tions of the amino acids with the solvent can become very
important for the protein stability, especially when the mu-
tation has a different hydrophobicity value than the native
residue.
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Protein–solvent systems have been studied on the atom-
istic level (see e.g., Dagget and Levitt, 1993; Karplus and
S˘ali, 1995 and references therein). These calculations can
reveal an accurate dynamics of these systems, but they are
limited to small proteins and short simulation times (the
time step for one integration is of the order of 1 fs).
Approaches that use a coarser model for the protein struc-
ture commonly use a dielectric function to describe the
solvent (Pappu et al., 1996; Ullner et al., 1996).
The goal of this approach is to develop a model that can
describe the interactions of a single protein with solvent. To
keep this model as simple as possible, we coarse-grain the
protein by introducing “effective atoms,” which carry the
main features of the part they represent (either backbone or
side chain). We then introduce a continuum approach where
the coordinates of each of the effective atoms and the
solvent are represented by a density. Applying a meanfield
approach to the system allows us to write down the free
energy of the system in a rather simple analytic form.
The advantages of this approach are: 1) The reduction of
the degrees of freedom allows for a faster sampling of the
possible conformations. It also smoothes the energy land-
scape, which makes it easier to move between the confor-
mations corresponding to global free energy minima of the
system. 2) The field theoretic approach allows for a self-
consistent search of the optimum conformation in a properly
weighted ensemble (field) of possible states. It also makes
the introduction of protein–solvent interactions in the form
of the inhomogeneous Flory–Huggins model for polymers
(Flory, 1953) straightforward. Though the meanfield ap-
proach includes naturally forbidden conformations (due to
packing constraints), this does not significantly reduce the
accuracy of the predicted side chain conformations limited
by the used intraprotein interactions (Va`squez, 1996).
Stability studies of proteins can be performed by calcu-
lating the free energy of static protein conformations start-
ing from the experimental known structure, then allowing
for small changes in the total protein conformation. Stable
structures are recognized by a local minimum in the free
energy. In particular, if we consider the stability of oli-
gomers, we can, in a first approximation, consider the
backbones of the different polypeptide chains to be rigid
and calculate the free energies of the protein with the single
chains at different separations.
We compare our computational results with experimental
data obtained from the protein p53 and mutations (C. H.
Arrowsmith, private communication; T. S. Davison, private
communication). Wild-type p53 is a sequence-specific
DNA binding protein and is recognized as one of the key
tumor suppressors in the human body (Friend, 1994). p53
consists of four equivalent polypeptide chains held together
through hydrophobic interactions. The three-dimensional
structure of this hydrophobic domain (or tetrameric domain)
has been obtained recently by nuclear magnetic resonance
(Clore et al., 1994, 1995a,b; Lee et al., 1994) and X-ray
crystallography (Jeffrey et al., 1995)) (Fig. 1). The tetramer
has three axes of two-fold symmetry and can be considered
as a dimer of dimers. Wild-type p53 in its tetrameric form
is most effective, but even monomeric and dimeric p53 has
some tumor-suppressing abilities. To understand the role of
monomeric/dimeric p53 in its function as tumor suppressor,
and the interplay of all four monomers during this process,
it is of interest to generate dimeric and monomeric p53.
Because the DNA binding sites are separate from the tet-
ramerization domain, mutations in the latter are not likely to
change the tumor-suppressing properties of monomeric/
dimeric p53. The most likely candidates for mutation are the
amino acids in the hydrophobic core of the tetramer, e.g.,
Met340.
p53 is a good candidate to evaluate the effectiveness of
our model. Its tetramerization domain can be viewed as a
dimer of dimers (Fig. 1), and a separation of these two
dimers (each of which consists of two -helices at the
interface, held together by a hairpin-like structure at their
back) most likely will not destroy their backbone confor-
mation (as long as the mutant amino acid preserves the local
secondary structure), thus allowing us to focus on the pro-
tein–solvent interactions without first solving the protein-
folding problem.
Replacing single amino acids in proteins (site-directed
mutagenesis) is now a standard technique in molecular
biology, but still requires some effort. A useful computer
model could allow one to evaluate potentially disruptive
mutation sites and candidates, thus limiting the number of
mutations to be generated in the laboratory.
The manuscript is organized as follows: In the next
section, we explain our model in some detail. The following
section reviews the interactions used for the numerical
calculations. The application to p53 is discussed in the
FIGURE 1 The tetramerization domain of p53 (amino acids Gly-325
through Ala-355) from a side view. The site 340 used for the single-point
mutations is highlighted, showing the wild-type amino acid methionine
(yellow). The arrow labeled x indicates the direction of the dimer–dimer
separation.
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section, “Application to p53,” and, in the next section, we
present our results and compare them to experimental data.
The final section concludes with a short summary.
MODEL
The goal of this section is to rewrite the partition function of
a polymer–solvent system in such a way that its free energy
can be approximated in a systematic and consistent way.
The starting point of our approach is the partition function,
Z 
n1
N
dxn 
j1
Ns
drjeV({xn},{rj}), (1)
where  is partition function related to the total kinetic
energy, N is the total number of particles in the polymer, NS
is the number of solvent molecules, xn is the position of
particle n, and rj is the position of solvent molecule j.
V({xn}, {rj}) denotes the potential energy,  1/kBT where
T is the temperature and kB is Boltzman’s constant. The
particles can be atoms or, more generally “effective atoms,”
i.e., sets of atoms within functional groups of the polymer.
In the latter case, xn would represent the center of mass
(cms) of this effective atom. This approach to represent a
group of real atoms as a single entity is especially useful for
biopolymers where the building blocks are typically mono-
mers with a distinct chemical or biological functionality. In
the context of our goal, we group atoms together, which build
up small domains of equal hydrophobicity/hydrophilicity.
In a first step we characterize each effective atom by a
density,
ˆnx x xn, (2)
and the solvent by the density
ˆSx 
j1
Ns
x rj. (3)
Using standard density functional techniques we can gen-
eralize the densities from the delta distributions in Eqs. 2
and 3 to continuous functions 	(x), 	  1, . . . , N, S
(Appendix A). By doing this, we also introduce for each
density 	(x) a conjugate field 
	(x).
The resulting partition function, Eq. A5, is equivalent to
the original form Eq. 1, but describes the system in terms of
the densities 	(x) and their conjugate fields 
	(x). Though
we have not gained any advantage in solving the thermo-
dynamics of the system exactly, we have now an expression
that allows us to apply systematic approximations.
In particular, we replace the partition function, Eq. A5, by
the extremum of its integrand, i.e., we consider only those
fields 	(x) and 
	(x), 	  1, . . . , N, S, which fulfill the
conditions
	, 
		
	x
 0,
	, 
		

	x
 0. (4)
By doing this approximation, we replace the detailed inter-
actions between the different components of the system by
the average of all the interactions each of the single com-
ponents sees. This approximation is called “Meanfield Ap-
proach” (Hong and Noolandi, 1981; Noolandi and Hong,
1982).
Using the equations derived in Appendix A, we can
rewrite Eqs. 4 as
nx
1
Qn
e
n(x)

nx 
m1
N  dxVnmx xmx
 dxVnSx xSx Wnx (5)
Sx
1
QS
e
S(x)

Sx 
n
 dxVnSx xnx,
where Qn is given by Eq. A4. Vnm and VnS are, respectively,
effective atoms and effective atom–solvent pair potential
energies. Wn is a single-body potential energy for effective
atom n.
Substituting Eqs. 5 back into Eq. A7, we find for the
Helmholtz free energy ,

1
2 
n1
N  dxnx
nx Wnx	


n1
N  dxnxlnnxn3


1
2  dxSx
Sx

 dxSxlnSxS3, (6)
where i3  h2/2mi, i  1, . . . , N, S.
The different terms of the free energy have the following
meaning:
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a. The first and third terms describe the enthalpic energies
arising from the particle–particle and particle–solvent in-
teractions, respectively. Note that half of the particle–
solvent interactions for each of the residues n is hidden in

n(x).
b. The second and fourth terms describe the entropy of the
particles and the solvent, respectively. The entropy for
the effective atoms arises because we consider the prob-
ability distribution of its cms position, which has a finite
width due to the finite number of locations at which the
particle can be found. In the case of a well-localized
particle n, n(x) reduces to a -function, and the entropy
of the particle becomes zero.
The interaction between the solvent and the polymer
takes place at their mutual interface. So far we have calcu-
lated the density distributions of the effective atom center-
of-mass positions. If the size of the effective atoms is not
negligible, as is the case for situations where they represent
groups of real atoms, we have to map the cms density
distribution to the interface of the effective atom. If we
assume each effective atom to be a sphere with effective
atom-dependent radius Rn, we can define a volume fraction
as
nx  dyKnx yny, (7)
with the kernel
Knx  Kn0 ; x Rn0; else. (8)
Figure 2 shows schematically how this mapping works:
n(x) is 1 at places that are always occupied by effective
atom n; the interface is defined as the region that is occupied
by the effective atom with a finite probability less than 1.
The Kn0 are normalization constants that are chosen such
that 0  n(x)  1 everywhere in the system. Different
shaped effective atoms are easily represented by more com-
plex kernels. For the solvent volume fraction we use
Sx
Sx
0S
, (9)
where 0S is the solvent bulk density.
By using volume fractions in Eqs. 5 and 6 instead of
densities and following the inhomogeneous Flory–Huggins
model for polymers (Flory, 1953) we can rewrite the con-
tributions of the solvent–polymer interactions to the free
energy as
S 
n1
N
n
V  dxnxSx 0S dxSxln Sx.
(10)
Within this model, the effective atom–solvent interaction
potential VnS is replaced by a contact interaction described
by the parameter n. Because of the incompressibility of the
system, i.e.,

n1
N
nxSx 1, (11)
Eq. 10 has nonzero contributions only, where n(x) and
S(x) overlap, i.e., at the mutual interface of the effective
atom and the solvent.
INTERACTIONS FOR A
PROTEIN–SOLVENT SYSTEM
We will now consider the special case of a protein–solvent
system. Interprotein interactions and protein–solvent inter-
actions have been studied by several groups at various
levels of detail. For our purpose of studying the stability of
the p53 tetramerization domain subjected to site-directed
mutagenesis, we consider a coarse-graining of the protein
by describing each amino acid by two effective atoms: one
representing the backbone properties and sitting at the C
position, the other representing the side chain properties and
sitting at the side chain cms position. By doing this coarse-
graining we lose information of the exact space-filling of
the protein, but we keep the information about the solvabil-
ity of the side chains which we believe is a major driving
force of the p53 mutants to remain as a stable tetramer, or
to dimerize.
Intraprotein interactions
For the interactions between the different effective atoms
within the protein, we use tabulated force fields obtained by
Kolinski and Skolnick (1992, 1994) and Vieth et al. (1994).
FIGURE 2 Mapping the cms density  to the effective atom volume
fraction . (A) Volume fraction of an effective atom (n  (x  xn)). (B)
Volume fraction of an effective atom with cms distribution  given by the
dashed curve.
Meanfield Model for Protein–Solvent Solutions 1527
Biophysical Journal 80(3) 1524–1537
These authors consider a similar coarse-graining as we do
for their protein-folding model. Because we always start
with an experimentally determined protein structure, we use
only the two-body interactions, but neglect the higher-order
interactions that were introduced by Kolinski et al. (1993) to
enhance the formation of secondary structures and to correct
for the discretization effects of their lattice model. We also
neglect their single-body interactions, because they were
introduced to mimic the solvent interactions, which we
include explicitly into our model. The two-body interactions
are estimated as (Godzik et al., 1995)
ijln
Nij
Nij
, (12)
where Nij is the number of contacts between amino acids i
and j as found in real proteins and Nij is the average
number of contacts between the same two amino acids in a
completely random protein. Whereas Kolinski et al. (1993)
use the ij as constant interaction potentials between effec-
tive atoms (C, side chains) i and j separated by distance rij
within a certain contact distance Rij,
VijKrij 
Vrep rij Rijrep
ij Rijrep rij Rij and ij 0
fijij Rijrep rij Rij and ij 0,
(13)
we use the ij as amplitudes of 1/r2 potentials with the same
range Rij
Vijrij 
VijKrij rij Rijrep

VijKrij
ij
1rij2  1Rij2 Rijrep rij Rij . (14)
For close encounters rij Rijrep, a repulsive “penalty” energy
Vrep  6 is considered. The factor
fij 1 cos2ui , uj cos2202, (15)
with ui  ri
2  ri2 (ri is the coordinate of the ith C on
the backbone) reflects the average angle between elements
of secondary structure seen in globular proteins. The contact
distances Rij are estimated as the distance between two
amino acids with their heavy atoms not more than 4.2 Å
separated from each other. See Kolinski and Skolnick
(1994) for more details. The normalization constants ij are
chosen such that the average interaction energies VijK(rij)
and Vij(rij) are the same within the spherical shell Rijrep 
rij  Rij.
So far, we have not included any bond-length and bond-
angle constraints. In a first approximation, we assume that
the cms position of each amino acid side chain remains at
the same position x0,n (relative to its neighbors) as in the
wild-type configuration, whereas its distribution function
(x) may change from -function with changes applied to
the protein. To accomplish this, we add to Eqs. 5 the
constraint
 dx xx x0,n . (16)
Because the side chains of the mutant amino acids differ
in size and composition from the wild-type amino acid, we
must relax this constraint. However, we know that the
amino acid side chains can exist only in a finite number of
conformations (so-called rotamers or rotameric states) due
to geometric constraints (Ponders and Richards, 1987;
Tuffery et al., 1991, 1992; Dunbrack and Karplus, 1993).
We use the rotamer library of Tuffery et al. (1991) including
the minor changes suggested by Koehl and Delaru (1994).
Using tabulated torsion angles and well-known values for
the bond lengths and angles within the 20 amino acids, we
construct a table of cms positions for all the rotamers.
These rotameric states act like internal degrees of free-
dom for each amino acid side chain and can be introduced
into the partition function as described in Appendix B. In
the ideal case, where the side chains can assume only
configurations corresponding to the rotameric states, the
f(tn) in Eq. B1 are products of -functions. Because of the
coarse-graining of the amino acid side chains into effective
atoms, we replace these -functions by Gaussian functions
with a finite width. The function Sn(x) as defined in Eq. B10
then becomes
Snx 
j1
Nn fnj
w3/2 exp x Rrot,nj
2
w , (17)
with fnj describing the relative weight of rotamer j of side
chain n, and w describing the width of the Gaussian.
Note: Some authors (Koehl and Delaru, 1994; Roitberg
and Elbers, 1991) working on the optimization of the side
chain packing for a given amino acid sequence and back-
bone conformation used the term meanfield approach when
they calculated the interactions of a given side chain with
the (weighted) sum of all the possible conformations of the
neighboring side chains. In this paper, the meanfield ap-
proach is implemented when approximating the free energy
functional Eq. A7 by its extremum (cf. Eq. 4). The weighted
sum of all the rotameric states of all the amino acid side
chains, which adds the harmonic potentials Eq. 17 to the
interaction term (cf. Eq. B14), is an immediate consequence
of counting all possible protein configurations in the parti-
tion function Eq. 1 at the start of our calculations.
Protein–solvent interactions
The interactions between the solvent and the amino acid
side chains are characterized by the parameters n in our
model (Eq. 10). n describes the hydrophobic/hydrophilic
character of amino acid n. Hydrophobic indices F(n) have
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been estimated by Fauche`re and Pliska (1983) by comparing
the distribution coefficients of amino acid amides in water
and n-octanol and fixing the absolute scale such that
F(Gly)  0. Eisenberg and McLachlan (1986) used these
values to estimate reduced solvation free energies per amino
acid Gn  2.3RTF(n)(kcal/mol). For our model, we de-
fine
n CPSV2/3
Gn
Sn
, (18)
where n labels the amino acid, Sn is the free surface area of
side chain n (estimated by the method suggested by Lee and
Richards, 1971), and CPS is a factor common to all the n,
which allows us to calibrate the numerical protein–solvent
interaction strength from experimental results.
APPLICATION TO p53
As a first application for the above-introduced meanfield
approach, we study the stability of the tetramerization do-
main of the tumor suppressor protein p53, without and with
single-point mutations. Figure 1 shows the tetramerization
domain of p53 for amino acids Gly-325 through Ala-355 for
each of the four polypeptide chains. Each two of the four
polypeptide chains form a dimer. Each of these dimers has
a large hydrophobic interface, and the tetramer forms by
binding the two dimers at their hydrophobic interfaces.
Single-site mutations of amino acids at this hydrophobic
interface are very likely to destabilize the tetramer, while,
by choosing the proper mutant amino acid, keeping struc-
tural changes to each of the dimers at a minimum.
To study the stability of the tetramerization domain for
the wild-type and the different mutations, we calculate free
energies for different configurations of the tetramerization
domain and estimate their dissociation energies. In particu-
lar, we use the high symmetry of the tetramerization domain
to calculate the energy as function of the mutual separation
d of the two dimers (the left and right one, respectively in
Fig. 1), where d measures the distance of the two dimers
along the direction perpendicular to their plane of symmetry
(direction of x in Fig. 1). The existence of a minimum in the
free energy and its depth and width will tell us about the
stability of this domain. Single-point mutations on either
site 340 or site 344 are performed by replacing the hydro-
phobic methionine or leucine with the same set of more
hydrophilic amino acids (Table 1) that were used in an
experimental study (C. H. Arrowsmith, private communica-
tion; Noolandi et al., 2000). These amino acids represent a
spectrum of different hydrophobicity indices  (Fauche`re
and Pliska, 1983; Eisenberg and McLachlan, 1986), but all
of them are considered to be reasonably good -helix form-
ers as indicated by their helical potentials P (Chou and
Fasman, 1974) (Table 1). As can be seen from Fig. 3, both
Met-340 and Leu-344 are located roughly at the center of
the long axis of the tetramerization domain. Destabilizing
the tetramer at this position promises to be most efficient.
By moving the two dimers perpendicular to their plane of
symmetry, we can assume that the internal structure of the
two dimers does not change. Therefore, we simplify our
calculations by keeping all backbone residues fixed at their
experimentally determined positions. Furthermore, we as-
sume that the side chains not located at the dimer–dimer
interface will keep their structure and position during the
dimer–dimer separation, hence, we keep them fixed at their
experimentally determined positions as well. There are 32
amino acids, each interacting with the opposite dimer (see
Fig. 3 and Table 2). Furthermore, there are the four Phe-341
amino acids that are located at the center of the interface.
Though none of these four amino acids interacts directly
with the opposite dimer, they may play an important role for
the tetramerization domain due to their hydrophobic char-
acter, which prefers to avoid direct contact with the polar
solvent (water). This leaves us with 36 side chains to which
TABLE 1 List of amino acids used as replacements for Met-
340 and Leu-344 with their respective hydrophobicity index 
(Eisenberg and McLahan, 1986) and helical potential P (Chou
and Fasman, 1974)
Met-340 Leu-344
Amino
Acid  P
Amino
Acid  P
Met 1.68 1.20 Leu 2.32 1.34
His 0.42 1.24 Ala 0.18 1.45
Ser 0.05 0.79 Arg 0.05 0.79
Gln 0.30 1.17 Gln 0.30 1.17
Glu 0.87 1.53 Lys 1.35 1.07
Asp 1.05 0.98
Lys 1.35 1.07
FIGURE 3 Top view of the tetramerization domain of p53 (amino acids
Gly-325 through Ala-355) with all the amino acids at the dimer–dimer
interface shown in a spacefilling mode. The four Phe-341 amino acids sit
in the “hole” at the center of the interface region.
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we apply our meanfield approach to calculate their cms
distribution and interaction energy with the solvent.
The calculation is done in several steps. First, we calcu-
late the cms distribution of the 36 interface amino acid side
chains by self-consistently solving Eqs. 5. In a second step,
we map the cms densities onto volume fractions using Eqs.
7 and 8. The effective atoms are considered spherical with
a radius Rn  Rms,n (cf. Appendix C), i.e., we chose Rn to
be the radius of the minimal sphere into which the residuum
n can be fitted (cf. Table 3). This results in a higher
space-filling than observed in real proteins. In contrast, our
procedure guarantees a complete overlap of the different
amino acids within the -helices, where one does not expect
any solvent, but allows for sufficient interaction with the
solvent at the interface as one would expect for the rather
long side chains of Met, Lys, Glu, and Gln. The solvent
volume fraction is obtained from Eq. 11 as
Sx 1 
n1
N
nx. (19)
Because the side chain cms distributions have been calcu-
lated without a constraint enforcing Eq. 11 at each space
point, we set S(x) to zero whenever n n(x) exceeds 1.
This guarantees that we get contributions to the free energy
only at the solvent–side chain interface (where 0 S(x)
1), but not spurious ones from the interior of the protein. (It
also means that the extensive and unphysical overlap of the
side chains within the polypeptide chains introduced by our
spherical approximation of the side chains only keeps the
solvent out, but does not lead to any contributions to the free
energy we try to estimate.)
RESULTS
The wild-type
The free energy calculated with the meanfield approach
consists of two parts. The interprotein interactions are cal-
culated self-consistently and represent the interactions be-
tween the different residues that are within contact distance.
For the free energy as a function of dimer–dimer distance,
we observe a strong increase in energy for small separations
where the amino acids start to overlap. However, even for
the wild-type, we do not observe a minimum in the free
energy that is deep enough to account for the experimentally
observed stability of this domain (Fig. 4 A) [Note: We are
interested in relative changes of the free energy as a func-
tion of dimer–dimer distance d. For a better comparison, we
move each of the free energy curves shown in Figs. 4–9 by
a constant amount such that the free energy for large sepa-
rations is zero.] The protein–solvent interactions add an
enthalpic and an entropic contribution to the free energy.
TABLE 2 List of all the amino acids at the
dimer–dimer interface
Amino
Acid Position  Color
Met 340 1.68 yellow
Glu 343 0.87 bright red
Leu 344 2.32 green
Ala 347 0.42 dark grey
Leu 348 2.32 green
Leu 350 2.32 green
Lys 353 1.35 blue
Gln 354 0.30 cyan
The colors refer to Figs. 1 and 3.
FIGURE 4 Reduced free energy  of the p53 tetramerization domain
as a function of dimer–dimer distance d. A distance of d  0 corresponds
to the experimental separation distance of the two dimers. (A) Comparison
of the free energies calculated with the full meanfield approach, with the
meanfield approach without protein–solvent interactions, and with no
meanfield approach (i.e., all residues are kept at the experimentally deter-
mined positions), respectively. (B) The different contributions to the free
energy calculated with the full meanfield approach.
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The enthalpic part accounts for the hydrophilic/hydrophobic
character of the amino acids in contact with the solvent and
increases with increasing dimer–dimer distance. This is
expected, because more and more of the hydrophobic amino
acids become exposed to solvent during separation. The
entropic term decreases with increasing d, but it changes
much less than the enthalpic term. The sum of these two
terms results in a net increase in solvent–protein interaction
energy with increasing dimer–dimer distance (Fig. 4 B).
The combination of interprotein and protein–solvent inter-
actions leads to a minimum in the free energy of the wild-
type tetramer of p53 that can account for the experimentally
observed stability of this domain.
The meanfield approach introduces several length scales
into the calculations. We first calculate the cms distributions
i(x) by self-consistently solving Eqs. 5. The cms densities
i(x) are expected to be well-localized functions around the
average position of the effective atom. Hence, we can limit
the space used for calculating the cms densities to a finite
spherical volume centered at each effective atoms cms
position. The effective atom-dependent radius of the spher-
ical volumes are CV  Reff,i, where Reff,i is the effective
radius of effective atom i defined in Appendix C. Figure 5
shows free energies for three different values of the constant
CV. Because the cms densities of the residues are very well
localized, the free energy does not depend much on the
change in the integration volume for CV  1. For all
calculations presented here, we use a value of CV  3.4, if
not mentioned otherwise.
We also introduce an excluded volume centered at each
effective atom’s cms position, into which no other effective
atom is allowed to penetrate. This prevents the densities
from overlapping too extensively with their neighbors. We
have chosen a spherical volume with a radius of CX  Reff,i
to specify this region. Because of the localized nature of the
residue’s cms positions, we do not see any significant de-
pendencies for values of CX  0.5, and chose a value of
CX  0.25 for all the calculations presented in this report.
When we map the cms position density i(r) into the
volume fraction i(r) of the residuum (cf. Eqs. 7 and 8), we
use the radius Rms,i CAA  Reff,i (cf. Appendix C). A value
of CAA  2.44 has been estimated by using the size of the
amino acids found in Lehninger (1977). Any change to CAA
has large effects on the free energy of the tetramerization
domain, as shown in Fig. 6. By changing CAA, the interac-
tion energy with the solvent is modified, though it impacts
the interactions most at larger distances. For all calculations
presented here, we use a value of CAA  2.44, if not
mentioned otherwise.
The interprotein interactions are defined with a finite
interaction range (cf. Eq. 14). The free energy of the pro-
tein–solvent system depends significantly on the range of
the interprotein interactions, both in the absolute values and
in its dependence on the interdimer distance d. We have
introduced a scaling factor Cint for the interprotein interac-
tion cut-off distance (scaling of contact distances Rij in Eq.
14). Figure 7 shows the free energy as a function of d for
three different values of Cint. Only for values of Cint less
than 1 can we obtain a minimum in the free energy that is
close to d  0, i.e., the experimentally observed interdimer
distance. With increasing value of Cint the amino acids
overlap much more and extend the repulsive part of the free
energy to larger values of d. For all calculations presented
here, we use a value of Cint  0.85, if not mentioned
otherwise.
The interaction parameters for the interprotein interac-
tions and for the protein–solvent systems are determined by
FIGURE 6 Reduced free energy  of the p53 tetramerization domain
as a function of dimer–dimer distance d for different values of the volume
fraction mapping scale CAA.
FIGURE 5 Reduced free energy  of the p53 tetramerization domain
as a function of dimer–dimer distance d for different values of the inte-
gration volume scale CV.
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two completely different approaches (the interprotein inter-
actions are statistically estimated from many proteins in the
protein database, the protein–solvent interactions are esti-
mated from solvability experiments of single amino acids).
We introduce one additional factor that rescales the ratio of
these two energy scales. In the current approach, we keep
the interprotein interaction parameters as given in Kolinski
and Skolnick (1992), Kolinski et al. (1993) and Vieth et al.
(1994), but scale the protein–solvent interactions by a factor
CPS. Figure 8 shows the free energy for different values of
CPS. With increasing CPS, the solvent–protein interactions
become more dominant, deepening the minimum in the free
energy. From experiments, we know the dissociation energy
ED  23 kcal/mol of the wild-type, which translates into
about 35kBT. From Fig. 8, we observe that a value of CPS
6 results in a minimum in the free energy of about 35kBT.
We use this value for all the calculations presented here, if
not otherwise mentioned.
Mutations
Figure 9, A and B, show reduced free energies F of the
tetrameric region of p53 for different mutations of Met-340
and Leu-344 as function of the mutual distance d of the two
dimers, respectively. d is the relative dimer–dimer distance
compared to the wild-type experimental result (d 0). If no
FIGURE 7 Reduced free energy  of the p53 tetramerization domain
as a function of dimer–dimer distance d for different values of the inter-
action cut-off distance scale Cint.
FIGURE 8 Reduced free energy  of the p53 tetramerization domain
as a function of dimer–dimer distance d for different values of the protein–
solvent to interprotein energy ratio scale CPS.
FIGURE 9 Reduced free energy  as a function of the relative dimer–
dimer distance for p53 mutants with energy ratio parameter CPS  6. (A)
Mutations of Met-340; (B) Mutations of Leu-344. See the text for more
details on the figure.
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minimum in F with respect to d is observed, the tetrameric
state is not stable, and p53 forms dimers.
The calculations predict a decreasing stability of the
tetrameric state for the following amino acids at residue
340: Met (tetramer)  Ser, Asp, His, Gln  Glu, Lys
(tetramer), whereas experimental results (Noolandi et al.,
2000) show the following order: Met (tetramer)  Ser 
Gln  His, Lys  Asp, Glu (dimer). For residue 344, the
calculated trend was Leu (tetramer)  Ala  Arg, Gln, Lys
(dimer), and the experimental trend was Leu (tetramer) 
Ala, Arg, Gln, Lys (dimer). It appears that the inclusion of
protein–solvent interactions, which play an important role
in the dimer–dimer dissociation, compensate for the coarse-
grained description of the protein structure used in the
meanfield calculations. The only major discrepancy be-
tween the simulation results and the experiments involves
the Asp mutation at side 340: although the experiments
show that this mutant dissociates into dimers, the meanfield
calculation predicts stable tetrameric configurations for it.
However, for the numerical calculations, we assume that all
mutants retain the wild-type backbone structure. This might
no longer be true for this mutant as indicated by its low
melting temperatures and MD calculations (J. Wendling,
private communication). We also find a discrepancy be-
tween the simulation results and the experiments involving
the Lys mutation at residue 340, which is the least stable
mutant according to the numerical calculations. This may be
because lysine has a rather long and flexible sidechain with
both hydrophobic and hydrophilic character. This dualism is
not captured by our model that describes each amino acid
sidechain by a single point coordinate and potential.
We also note that the calculations describe a system in
infinite dilution (a single tetrameric molecule). Self association
of proteins is highly concentration dependent and the relatively
high concentrations used for CD and light scattering will drive
the dimer–tetramer equilibrium toward the tetrameric state.
It is interesting to note that, although the trends in oligo-
meric state determined by meanfield calculations agree well
with the experimental data, they do not directly correspond
to the hydrophobicity index (Eisenberg and McLachlan,
1986). For example, His has a relatively high value on the
hydrophobicity index (0.18) (compared to other mutations,
cf. Table 1) yet His-340 is predicted to be more dimeric than
Ser-340, which has a hydrophobicity value of 0.05. This
trend is also observed experimentally, where His-340 is
more dimeric than Ser-340 and Gln-340. In the case of His,
the important feature is likely the relatively large and rigid
shape of the His sidechain, which is not as easily accom-
modated at the dimer–dimer interface as Ser or Gln. Be-
cause each side chain in the meanfield calculation is treated
as a single effective atom, sidechain geometrical constraints
are not fully captured in the calculated free energy. How-
ever, the meanfield approach is still able to incorporate
multiple properties of amino acid sidechain in most cases.
A comparison of the simulation and experimental (Noo-
landi et al., 2000) results suggests that p53tet is more
sensitive to changes at residue 344 than at residue 340. For
example, Lys-344 is a dimer with TM 48°C, but this same
mutation at residue 340 has a Tm of 66°C and exists as an
equilibrium mixture of dimers and tetramers. This differ-
ence in sensitivity can be rationalized by noting that the
sidechains of residue 344 from all 4 subunits are closer to
one another than those of residue 340 (Fig. 3). This will
result in more charge repulsion at the dimer–dimer interface
for Lys-344 than for Lys-340. The solvation of this interface
in the dimer would relieve charge–charge repulsion be-
tween the two Lys sidechains in the dimer. It is also possible
that the sidechain of Lys-340 can adopt a conformation such
that the hydrophobic portion of the sidechain associates
with the opposite dimer, while the charged portion has
access to the solvated surface of the tetramer.
CONCLUSION
We have introduced a method to calculate protein–solvent
interactions based on a meanfield approach to the partition
function of the system. An advantage of this approach is the
introduction of fields for the different residues of the sys-
tem. This reduces the many solvent molecules needed for an
atomistic calculation to a single field and allows the use of
a Flory–Huggins type of contact interaction between the
protein and the solvent. We have applied this method to study
the stability of the tetramerization domain of the tumor sup-
pressor p53 when subjected to single-point mutations at sites
340 or 344. Here, the secondary structure of the protein sur-
vives the mutation, but not necessarily the quaternary structure,
leading to a dissociation of the protein into two dimers. This
dissociation is mainly driven by the amino acid–solvent inter-
actions, which prefer an exposed dimer–dimer interface for the
more hydrophilic amino acids at sites 340 or 344.
Comparison with recent experiments on the stability of
the p53 tetramerization domain shows that our meanfield
representation of a solvent–protein system can predict the
major features of a small self-associating protein system
with reasonable accuracy.
Though we introduce several “free” parameters into our
approach, we believe that our choice of parameters is gen-
eral to other proteins besides p53: The length scales CV
(integration volume) and CX (excluded volume around the
center of each effective atom) have no significant impact on
the meanfield calculation within the range defined in sub-
section, The wild-type. The length scale CAA has been
chosen such that the interface between the volume fraction
and the surrounding solvent is at the location expected for
the amino acid sidechains. Even though the free energy
depends on the explicit value of this parameter, we believe
that our choice is physically sound and general (at this level
of approximation) for all proteins. The parameter Cint used
to scale the range of the interprotein interactions has been
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chosen such that we can obtain reasonable values of the
interdimer distance of the wild-type tetramer. The value of
Cint  0.85 is in agreement with observations of other
groups that use the Skolnick interaction parameters in their
(continuous space) calculations (F. Cohen, private commu-
nication). The energy scale CPS for the protein–solvent
interactions is the only parameter that has been obtained
using explicit data for p53 by fitting the calculated dimer–
dimer dissociation energy to the experimental result. How-
ever, using this set of parameters for calculating dissociation
energies of other quaternary proteins that are bound together
primarily by hydrophobic interactions also gives good
agreements with experimental results (e.g., for streptavidin,
Coussaert et al., 2000).
Overall, the results presented here are encouraging for the
application of the meanfield method toward other more
complicated protein–solvent systems. Also, using more so-
phisticated intraprotein interaction schemes, this method is
readily extended to situations where the secondary structure
might also change significantly with the exchange of amino
acids along the protein backbone.
APPENDIX A: DENSITY FUNCTIONAL APPROACH
Using the densities defined in Eqs. 2 and 3, we can rewrite the integrand
of Eq. 1 as
eV  
	1
N
1
	x		x ˆ	xeW[	], (A1)
where we introduced a single index 	 to address the effective atoms (	 
1, . . . , N) and the solvent (	  N 
 1) together.
If we assume single- (W) and two-body interactions (Vnm) within the
effective atoms, and two-body interactions between the solvent and the
effective atoms (VnS), we have
W		
1
2 
n,m1
N  dx dxnxVnmx xmx


n1
N  dxnxWnx


n1
N  dx dxnxVnSx xSx. (A2)
Rewriting these -functions, we introduce conjugate fields 
	(x) for each
density 	(x),
	x ˆ	x
 
	r	exp dx
	x	x ˆ	x. (A3)
By defining
Q	   dx	exp dx
	xˆ	x  dx	e
	(x	), (A4)
we finally obtain the partition function,
Z  
	1
N
1
		
		e[	,
	], (A5)
with
	 , 
		
 
	1
N
1 ln		3Q	
  dx	x
	x W	x	. (A6)
In the case where a subset Nc  N of effective atoms is kept fixed at
positions {xk0}, k  1, . . . , Nc, we start with the partition function
Z 
k,l1
Nc
exp	 12 Vklxk0 xl0


k1
Nc
expWkxk0d
 
n1
Nd
dxn 
j1
Ns
drj expV˜xn, rj, (A7)
where
V˜xn, rj)

1
2 
n,m1
Nd
Vnmxn xm 
n1
Nd
Wnxn
 
n1
Nd 
k1
Nc
Vnkxn xk0 
n1
Nd 
j1
Ns
VnSxn rj
 
k1
Nc 
j1
Ns
VkSxk0 rj, (A8)
and Nd N Nc. The interactions of the effective atoms in subset Nd with
those of subset Nc (the third term on the right-hand side of Eq. A8) and
those of the effective atoms in subset Nc with the solvent (last term on the
right-hand side of Eq. A8) are effective single-body energies and can be
included into Wk(xk). This leaves us with the same type of partition
function as discussed above with the only change that N is replaced by the
number of effective atoms in subset Nd.
APPENDIX B: PARTITION FUNCTION FOR
PARTICLES WITH INTERNAL
DEGREES OF FREEDOM
In this Appendix, we will consider a system of N particles with internal
degrees of freedom. In particular, we assume particle n to have Tn internal
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degrees of freedom, each of which is assumed with the position-dependent
probability fnk(x), k  1, . . . , Tn. The partition function for this type of
system is
Z  
n1
N
dxn
tn
ftnexpVxn, tn, (B1)
where {tn} denotes the sum over all possible permutations of the internal
degrees of freedom, and f({tn}) is the total probability of permutation {tn}.
Following the field theoretical approach described in Appendix A, we
introduce densities
ˆnkx x xntnk (B2)
for each degree of freedom for each particle. Using the same steps as
before, we can rewrite the partition function in generalized densities nk(x)
and their conjugate fields 
nk(x) as
Z  
	1
N
1 
k1
Tn
nk	
nk	exp	 , 
		, (B3)
with the free energy functional
nk , 
nk	
 Wnk	 
n1
N 
k1
Tn  dxnk
nk 
n1
N
lnn3/Qˆn. (B4)
The integrals
Qˆn  dx e
eff,n(x) (B5)
contain now the weighted sum over all the conjugate fields of one particle

eff,nxln	
k1
Tn
fkxe
nkx
. (B6)
Within the meanfield approximation, the fields are given by

nkx
Wnk	
nkx (B7)
nkx
e
eff,n(x)
Qˆn
fkxe
nk(x)l1Tn flxe
nl(x) .
In the special case when the interactions W[nk] are independent of the
internal degrees of freedom of the particles, the conjugate fields are all the
same, i.e., 
nk(x)  
n(x), and are given as

nx
Wnk	
nx
, (B8)
where
nx 
k1
Tn
nkx. (B9)
Furthermore, by defining
Snx 
k1
Tn
fnkx, (B10)
we obtain

eff,nx
nx ln Snx (B11)
and
nx
e
n(x)
Qˆn
. (B12)
The Helmholtz free energy (Eq. 6) finally becomes
nk , 
nk	 
n1
N  dxnxln nx


nx Wnx 2 ln Snx
2 . (B13)
This system is equivalent to one with no internal degrees of freedom of the
particles, but with the renormalized single-particle energy,
Wnx 3 Wnx ln Snx, (B14)
as can be seen directly from the initial partition function Eq. B1, when the
fk(x) are added to the interactions in the exponent.
APPENDIX C: EFFECTIVE ATOMIC RADII
For each effective atom, we define a radius Reff,i, (i counts the 20 amino
acid side chains plus the backbone) as the radius of a sphere that has the
same volume as all the heavy atoms (C, N, O, S) of the effective atom
Reff,i  
heavy atoms (ha)
Rha,i3 1/3. (C1)
This radius correlates very well with the radius Rms,i of the minimal sphere
needed to fit in effective atom i as estimated from size data given in
Lehninger (1977) (Table 3). The ratio CAA of the Rms,i and the effective
TABLE 3 List of the effective (Reff) and “minimal sphere”
(Rms, Appendix C) radii of the residues in units of Å
Residue Reff Rms Residue Reff Rms Residue Reff Rms
Cyx* 1.15 3.2 Gly† — — Ala 0.77 1.8
Ser 0.88 2.1 Cys 1.16 2.5 Val 1.11 2.8
Thr 1.04 2.5 Ile 1.23 3.2 Pro 1.11 3.35
Met 1.36 3.05 Asp 1.11 2.5 Asn 1.09 2.65
Leu 1.23 3.05 Lys 1.26 2.95 Glu 1.22 2.9
Gln 1.21 2.9 Arg 1.33 3.75 His 1.29 3.05
Phe 1.48 3.5 Tyr 1.51 3.35 Trp 1.63 4.15
*The symbol Cyx denotes the backbone effective atom.
†Because the side chain of glycine consists of a single hydrogen only no
effective radius has been calculated.
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radii Reff,i is about the same for each effective atom, and its averaged value is
CAA
1
NR

i1
NR Rms,i
Reff,i
 2.44 0.18, (C2)
where NR  21 is the number of the possible effective atoms.
We use the Reff,i as the basic size scale for each of the effective atoms,
and use constant factors (which are the same for all effective atoms) to
calculate specific size scales, such as integration volumes or excluded
volumes.
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